| PERIOD ENDING | 31-May-08 | 29-Feb-08 | 30-Nov-07 | 31-Aug-07 | | Total Revenue | 8,910,000 | 12,370,000 | 14,890,000 | 14,739,000 | | Cost of Revenue | 388,000 | 351,000 | 1,325,000 |
-
| | | Gross Profit | 8,522,000 | 12,019,000 | 13,565,000 | 14,739,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,031,000 | 2,493,000 | 1,835,000 | 3,103,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,670,000 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,821,000 | 9,526,000 | 11,730,000 | 11,636,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 2,821,000 | 9,526,000 | 11,730,000 | 11,636,000 | | Interest Expense | 6,908,000 | 8,863,000 | 10,500,000 | 10,431,000 | | Income Before Tax | (4,087,000) | 663,000 | 1,230,000 | 1,205,000 | | Income Tax Expense | (1,313,000) | 174,000 | 344,000 | 318,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,774,000) | 489,000 | 886,000 | 887,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,774,000) | 489,000 | 886,000 | 887,000 | | Preferred Stock And Other Adjustments | (123,000) |
-
| (16,000) | (17,000) | | | Net Income Applicable To Common Shares | ($2,897,000) | $489,000 | $870,000 | $870,000 |
|
0.63% Nasdaq 
0.03%
Income Statement
